一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

返回ChemicalBook首頁>CAS數(shù)據(jù)庫列表>216167-82-7

216167-82-7

中文名稱 AGI 1067
英文名稱 4-[4-[2-(4-hydroxy-3,5-ditert-butyl-phenyl)sulfanylpropan-2-ylsulfanyl]-2,6-ditert-butyl-phenoxy]-4-oxo-butanoic acid
CAS 216167-82-7
分子式 C35H52O5S2
分子量 616.91
MOL 文件 216167-82-7.mol
更新日期 2026/05/25 16:59:23
216167-82-7 結構式 216167-82-7 結構式

基本信息

中文別名
化合物SUCCINOBUCOL
英文別名
AGI 1067
AGZ-1067
SUCCINOBUCOL
SUCCINOBUCOL, >98%
Probucol Monosuccinate
Succinobucol(AGI 1067)
Probucol monosuccinate, >98%
AGZ1067. Probucol monosuccinae
AGI-1067
PROBUCOL MONOSUCCINATE
SUCCINOBUCOL
AGI-1067
AGZ-1067
AGI1067
AGZ1067. PROBUCOL MONOSUCCINAE

物理化學性質(zhì)

熔點139 - 142°C
沸點659.5±55.0 °C(Predicted)
密度1.13±0.1 g/cm3(Predicted)
儲存條件Sealed in dry,2-8°C
溶解度可溶于氯仿(少許)、甲醇(少許)
酸度系數(shù)(pKa)4.27±0.17(Predicted)
形態(tài)固體
顏色白色至淺黃色
InChIKeyRKSMVPNZHBRNNS-UHFFFAOYSA-N
SMILESOC1=C(C(C)(C)C)C=C(SC(C)(C)SC2=CC(C(C)(C)C)=C(OC(CCC(O)=O)=O)C(C(C)(C)C)=C2)C=C1C(C)(C)C

安全數(shù)據(jù)

危險性符號(GHS)有害 (GHS07)
GHS07
警示詞警告
危險性描述H302-H315-H319-H335
WGK GermanyWGK 3
存儲類別11 - Combustible Solids
AGI 1067價格(試劑級)
報價日期產(chǎn)品編號產(chǎn)品名稱CAS號包裝價格
2026/06/05HY-14937RAGI 1067
Succinobucol (Standard)
216167-82-75 mg720元
2026/06/05HY-14937RAGI 1067
Succinobucol (Standard)
216167-82-710 mg1200元
2026/06/05HY-14937RAGI 1067
Succinobucol (Standard)
216167-82-725 mg2400元

常見問題列表

生物活性
AGI-1067是一種新型的、酚類的細胞內(nèi)外抗氧化劑,可抑制一系列參與動脈粥樣硬化的促炎性基因的表達。
體外研究

Succinobucol (10, 50, 100 μM) causes a dose-dependent reduction in collagen-induced platelet aggregation in rabbit whole blood. Succinobucol also causes a significant reduction in whole blood aggregation in response to ADP. Succinobucol (10, 100 μM) significantly lowers the relaxation to X/XO. Succinobucol significantly prevents 3-NP-induced loss of SH-SY5Y cell viability, generation of reactive oxygen species, and decrease of ΔΨm. Succinobucol does not protect against 3-NP-induced inhibition of mitochondrial complex II activity, pointing to the mitigation of secondary events resultant from mitochondrial complex II inhibition. Succinobucol significantly increases (50 %) the levels of GSH in SH-SY5Y cells, which is paralleled by significant increases in glutamate cysteine ligase messenger RNA (mRNA) expression and activity. Succinobucol effectively exhibits superior inhibitory effects on cell migration and invasion activities, VCAM-1 expression and cell-cell binding of RAW 264.7 to 4T1 cells. Succinobucol also shows inhibitory effect on VCAM-1 expression in 4T1 cells and cell-cell binding of RAW 264.7 to 4T1 cancer cells.

體內(nèi)研究

Succinobucol (50, 100, and 150 mg/kg, i.v.) has no significant effect on either heart rate or MAP, but the blood removed 15 minutes after the final injection of succinobucol shows significantly less aggregation in response to collagen at both 5 μg/mL and 20 μg/mL in rats. Succinobucol (40 mg/kg) by tail injection significantly reduces the average number of metastatic nodules in lung metastatic breast cancer mice.

"216167-82-7" 相關產(chǎn)品信息
3561-67-9 23288-49-5 109-04-6
西昌市| 青河县| 祥云县| 綦江县| 苗栗县| 神农架林区| 江阴市| 定安县| 巩义市| 仁布县| 逊克县| 苏州市| 梅州市| 苍南县| 黄龙县| 衡水市| 仁怀市| 西乌珠穆沁旗| 滦平县| 无为县| 宜宾县| 偏关县| 营山县| 大埔县| 个旧市| 沙雅县| 沧源| 吉木萨尔县| 仲巴县| 普定县| 青川县| 五指山市| 岚皋县| 拜城县| 高台县| 天峨县| 嘉鱼县| 远安县| 郯城县| 延安市| 紫阳县|